Navigation Links
2-step immunotherapy attacks advanced ovarian cancer
Date:1/31/2013

PHILADELPHIA -- Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine show that a two-step personalized immunotherapy treatment a dendritic cell vaccine using patients' own tumor followed by adoptive T cell therapy triggers anti-tumor immune responses in these type of patients. Four of the six patients treated in the trial responded to the therapy, the investigators report this month in OncoImmunology.

"What we proved in this study is that this is a safe treatment strategy," says co-first author Lana Kandalaft, PharmD, MTR, PhD, research assistant professor of Obstetrics and Gynecology and director of clinical development in the Ovarian Cancer Research Center. "It is a walk in the park for patients, especially compared to standard chemotherapies and surgical treatments for ovarian cancer literally, some patients left the clinic and went for a walk in a nearby park after their treatment."

The findings follow research by the study's senior author, George Coukos, MD, PhD, director of the Ovarian Cancer Research Center at Penn, who showed in 2003 that women whose ovarian tumors were infiltrated by healthy immune cells, called T cells, tended to live longer than women whose tumors were devoid of T cells. That observation and other subsequent ones suggest the patient's immune system is trying to fight off the disease but can't quite muster the strength to beat it. Therefore, investigators have been trying to find ways using patients' own tumor cells to boost the immune system's power.

In the current study, Coukos, Kandalaft, co-first author Daniel J. Powell Jr., PhD, research assistant professor of Pathology and Laboratory Medicine, and colleagues treated six women with advanced ovarian cancer in a two-staged immunotherapy protocol in which they utilized a d
'/>"/>

Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. 12-Step Meetings May Help Teens Beat Alcohol, Drug Abuse
2. Immunotherapy reduces allergic patients sensitivity to peanuts
3. Sublingual immunotherapy shows promise as treatment for peanut allergy
4. Moffitt researchers say effective immunotherapy for melanoma hinges on blocking suppressive factors
5. Antibodies reverse type 1 diabetes in new immunotherapy study
6. Immunotherapy for elderly cancer patients finds new promise in drug combination
7. Toward a better cyanide antidote for terrorist attacks and other mass casualty events
8. New Guidelines Seek to Streamline Care for Worst Heart Attacks
9. Penn research reveals new aspect of platelet behavior in heart attacks: Clots can sense blood flow
10. Study Tallies Economic Fallout From Workers Heart Attacks
11. Decline in incidence of heart attacks appears associated with smoke-free workplace laws
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... (PRWEB) May 27, 2015 Continuing its ... of healthier patients in the community, SmartPractice® ... (formerly John C. Lincoln). SmartPractice Vice President of Human ... Shaw presented a $25,000 check to Paulla Miller, Sherry ... Breast Health & Research Center on April 30. The ...
(Date:5/27/2015)... Allred Dental located in San Marcos, CA came up ... dental treatment - understand the oral issues they are dealing ... , Dr. Jeff Allred calls it “Dental Case Planning” and ... the patient’s oral health and problems together with the first ... problems. , “The dental case planning process starts with the ...
(Date:5/27/2015)... Clearwater, Florida (PRWEB) May 27, 2015 ... accurate, impartial customer satisfaction surveys in the multiple ... user poll to determine the highest ranked Electronic ... As part of a special research focus on ... and announced those software vendors with the highest ...
(Date:5/27/2015)... 2015 The MedSpa at Hendrick is ... filler treatments in Abilene, Texas: Xeomin®, Belotero Balance® and ... of glabellar lines, better known as the lines between ... designed to treat smoker’s lines around the mouth and ... Radiesse® improves the appearance of smile lines or lines ...
(Date:5/27/2015)... May 27, 2015 Coco Libre announced today ... able to reach for Organic Coconut Water to quench their ... be available at VIP areas, artist greenrooms, corporate skyboxes and ... at area hotels and on festival shuttle buses. , ... year,” said Noa Elan, Director of Strategic Partnerships for Latitude ...
Breaking Medicine News(10 mins):Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2
... News) -- A newly published case history highlights the importance ... The report details a situation involving a stray dog found ... shelter in March 2010. When it was later learned that ... using animal shelter records and a public notification to identify ...
... Jan. 6 (HealthDay News) -- Nursing home residents with serious ... than those with no mental illness, researchers have found. ... about their future treatment or identify a person who will ... ill to do so. U.S. researchers looked at four ...
... , THURSDAY, Jan. 6 (HealthDay News) -- The cost of ... hospital is 12 times higher than in an outpatient clinic ... new study has found. PID is an inflammation of ... sexually transmitted diseases such as chlamydia and gonorrhea. PID can ...
... Alan Mozes HealthDay Reporter , THURSDAY, Jan. 6 ... wounded trauma patients intravenous (IV) fluids before bringing them ... death, a new study suggests. The finding flies in ... some states that require that IV fluids be given to ...
... cancer tissues are invaded by inflammatory cells that either stimulate ... immune cells are involved. Now a Swedish-Belgian research team has ... HRG, inhibits tumor growth and metastasis into secondary organs by ... in the Net edition of the prestigious journal ...
... clinical study to date of "Sarcoid Like" Granulomatous Pulmonary Disease ... rate of the condition was increased in this group as ... is published online in the American Journal of Industrial ... 20,000 responders who had an initial exam in the Mount ...
Cached Medicine News:Health News:Mentally Ill in Nursing Homes Often Lack Advance Care Plans 2Health News:Earlier Diagnosis Might Cut Cost of Teen Pelvic Disease 2Health News:Giving IV Fluids on Scene Might Raise Death Risk for Trauma Victims 2Health News:Giving IV Fluids on Scene Might Raise Death Risk for Trauma Victims 3Health News:Steering cancer inflammation to inhibit tumor growth and spread 2Health News:Study of 'sarcoid-like' granulomatous pulmonary disease finds elevated rates in WTC responders 2Health News:Study of 'sarcoid-like' granulomatous pulmonary disease finds elevated rates in WTC responders 3
(Date:5/27/2015)... , May 25, 2015 Research and ... the addition of the "2015 Strategies in ... their offering. This comprehensive five-country report ... to help current suppliers and potential market entrants ... European coagulation testing market during the next five ...
(Date:5/27/2015)... SALT LAKE CITY , May 27, 2015 /PRNewswire/ ... on a $10 million credit facility with Deerfield Management, ... be used to fund Vital Access, continued global expansion ... for further investment in the Company,s proprietary vascular access ... have Deerfield as a financial partner. Deerfield is a ...
(Date:5/27/2015)... DUBLIN , May 25, 2015 Research ... the "Global Rapid Medical Diagnostic Kits Market - ... Global market for Rapid Medical Diagnostic Kits, estimated ... in 2015 and further expected to maintain a CAGR ... projected US$27 billion by 2020. The global ...
Breaking Medicine Technology:European Coagulation Testing Market Strategies 2015 2Vital Access Receives $10 Million Financing Commitment from Deerfield 2Vital Access Receives $10 Million Financing Commitment from Deerfield 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 4
... 8 Patients with knee cartilage,injuries now have the ... study at TRIA Orthopaedic Center, in Bloomington, MN. Cartilage,is ... of your bones at a,joint such as the knee; ... In the United States alone, knee pain ranks the,second ...
... 8 Nastech Pharmaceutical,Company Inc. (Nasdaq: NSTK ... 2 clinical trial of PYY3-36 Nasal Spray to ... multiple clinical sites in the United States,for a ... designed to evaluate three different doses of PYY3-36 ...
Cached Medicine Technology:Knee Pain? An Exclusive Study Engineers Cartilage to Match Patient's Own Tissue 2Knee Pain? An Exclusive Study Engineers Cartilage to Match Patient's Own Tissue 3Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity 2Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity 3
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 20-200 Inaccuracy (%) ... Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: